Arkolith/Insider Trading/DMAC/Form 4

Kellen Scott

CFO and SecretaryDiaMedica Therapeutics Inc. (DMAC) · full profile →Form 4 · filed Jun 26, 2023
Net Buying
Open-Market Buys
$39K
Open-Market Sells
$0
Net Open-Market Flow
$39K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2023Buy(P)10K$3.91$39K32K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001235802-23-000070) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML